Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature

Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative people to prevent HIV infection. WHO released new guidelines in 2015 recommending PrEP for all populations at substantial risk of HIV infection. To prepare these guidelines, we conducted a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Koechlin, Florence M., Fonner, Virginia A., Dalglish, Sarah L., O’Reilly, Kevin R., Baggaley, Rachel, Grant, Robert M., Rodolph, Michelle, Hodges-Mameletzis, Ioannis, Kennedy, Caitlin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378753/
https://www.ncbi.nlm.nih.gov/pubmed/27900502
http://dx.doi.org/10.1007/s10461-016-1627-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378753/
https://www.ncbi.nlm.nih.gov/pubmed/27900502
http://dx.doi.org/10.1007/s10461-016-1627-z

Ejemplares similares